CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 202,039	$ 141,037
Non-controlling interests in subsidiaries' income (loss)	131	37
Net income including non-controlling interests	202,170	141,074
Adjustments to reconcile Net income including non-controlling interests to Net cash provided by operating activities:
Rationalization and asset impairment net (gains) charges (Note 6)	(1,162)	21,927
Depreciation and amortization	60,558	60,566
Equity earnings in affiliates, net	(399)	(323)
Deferred income taxes	(28,428)	(10,143)
Stock-based compensation	18,215	11,656
Pension settlement charges	80,098	6,522
Other, net	(754)	(10,805)
Changes in operating assets and liabilities, net of effects from acquisitions:
(Increase) decrease in accounts receivable	(71,212)	(6,851)
Increase in inventories	(128,856)	(3,430)
(Increase) decrease in other current assets	(10,610)	8,027
Increase (decrease) in trade accounts payable	54,981	(42,333)
Increase in other current liabilities	89,569	38,615
Net change in other assets and liabilities	(9,045)	1,059
NET CASH PROVIDED BY OPERATING ACTIVITIES	255,125	215,561
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures	(46,440)	(37,116)
Acquisition of businesses, net of cash acquired	(158,605)	0
Proceeds from sale of property, plant and equipment	3,847	6,957
Other investing activities	6,500	0
NET CASH USED BY INVESTING ACTIVITIES	(194,698)	(30,159)
CASH FLOWS FROM FINANCING ACTIVITIES
Amounts due banks, net	32,295	(33,135)
Proceeds from exercise of stock options	7,921	7,961
Purchase of shares for treasury (Note 8)	(103,848)	(113,198)
Cash dividends paid to shareholders	(91,717)	(88,945)
Other financing activities	(763)	0
NET CASH USED BY FINANCING ACTIVITIES	(156,112)	(227,317)
Effect of exchange rate changes on Cash and cash equivalents	(1,035)	(5,169)
DECREASE IN CASH AND CASH EQUIVALENTS	(96,720)	(47,084)
Cash and cash equivalents at beginning of period	257,279	199,563
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$ 160,559	$ 152,479